Jump to main content
Jump to site search


Recent advances in organ-on-a-chip: biomarker analysis and applications

Abstract

In pharmaceutical research and development, improving the effectiveness of preclinical predictions is significant, thus in vitro and in vivo experimental models are needed to investigate human drug responses in organisms. As microengineered model, Organ-on-a-chip (OoC) could provide reliable predictions of drug efficacy and safety by mimicking the complex biological functions of normal cellular interactions. It presents a novel platform with the advantages of high throughputs, low cost, and high efficiency for drug development. Here, we provide an outlook into the recent fundamental development of OoC studies and discuss the perspective of their applications in relation to drug discovery. In particular, we highlight a set of recently developed strategies that facilitate high-throughput analysis of biomarkers and drug metabolites on OoC, including ELISA, PCR, LC-MS and Lab-on-Chip. A brief summary is also presented along with a perspective of this field in the future.

Back to tab navigation

Publication details

The article was received on 30 Apr 2018, accepted on 24 May 2018 and first published on 28 May 2018


Article type: Minireview
DOI: 10.1039/C8AY00970H
Citation: Anal. Methods, 2018, Accepted Manuscript
  •   Request permissions

    Recent advances in organ-on-a-chip: biomarker analysis and applications

    X. Li and T. TIAN, Anal. Methods, 2018, Accepted Manuscript , DOI: 10.1039/C8AY00970H

Search articles by author

Spotlight

Advertisements